Comparison of three methods for total homocysteine plasma determination

T Brunelli1, G Pepe, R Marcucci

  • 1Dipartimento di Area Critica Medico-Chirugica, Università di Firenze, Italy. labctrombosi@ao-careggi.toscana.it

Clinical Laboratory
|August 14, 2001
PubMed

Insights

Hyperhomocysteinemia increases atherothrombotic disease risk. The fluorescence polarization immunoassay (FPIA) method is suitable for clinical laboratories to measure homocysteine plasma levels, showing good agreement with the reference method.

Area of Science:

  • Clinical Chemistry
  • Biomarker Analysis
  • Cardiovascular Disease Risk Assessment

Background:

  • Hyperhomocysteinemia is a recognized risk factor for atherothrombotic diseases.
  • Increasing demand for homocysteine testing necessitates reliable and accessible laboratory methods.
  • Accurate measurement of homocysteine is crucial for assessing individual cardiovascular risk profiles.

Purpose of the Study:

  • To compare the performance of two commercial immunoassays (EIA and FPIA) against a reference HPLC method for homocysteine plasma level determination.
  • To evaluate the suitability of the FPIA assay for routine use in clinical laboratories.

Main Methods:

  • Analysis of 100 plasma samples using an in-house high-pressure liquid chromatography (HPLC) method as the reference.
  • Measurement of homocysteine levels using a commercial enzyme-linked immunoassay (EIA) and an automated fluorescence polarization immunoassay (FPIA).
  • Statistical analysis including correlation and Bland-Altman analysis to assess agreement between methods.

Main Results:

  • FPIA demonstrated the lowest within-run (3.6%) and between-run (4.1%) coefficients of variation.
  • Significant correlations were observed between EIA and HPLC (r=0.81) and between FPIA and HPLC (r=0.85).
  • Bland-Altman analysis indicated that FPIA showed the best agreement with the HPLC reference method, while EIA had a wider scatter.

Conclusions:

  • The fluorescence polarization immunoassay (FPIA) exhibits excellent precision and strong correlation with the HPLC reference method.
  • The technological characteristics of the FPIA assay make it a suitable and reliable method for homocysteine determination in clinical laboratory settings.
  • FPIA offers a viable option for laboratories needing to accurately assess homocysteine levels for cardiovascular risk evaluation.

Related Concept Videos